Clinical Trial Update: An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT Disease [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update notes a Phase 1 study evaluating the safety, tolerability, and efficacy of HG005 for Stargardt disease, Type 1, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stargardt Disease

Drugs mentioned

• HG005

Snippet

Sponsor: HuidaGene Therapeutics Co., Ltd. | Conditions: Stargardt Disease Type 1 (STGD1) | EARLY_Phase 1 | Status: RECRUITING